Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HBIO attributes changed

  • Technical Exchange News
  • March 31, 2026, 02:14 UTC
  • 25
  • 0 comments

HBIO attributes changed: Attr: Fin_status D -> N;

Comment Full text

DGNX attributes changed

  • Technical Exchange News
  • March 31, 2026, 02:14 UTC
  • 20
  • 0 comments

DGNX attributes changed: Attr: Fin_status N -> D;

Comment Full text

CLIR attributes changed

  • Technical Exchange News
  • March 31, 2026, 02:14 UTC
  • 21
  • 0 comments

CLIR attributes changed: Attr: Fin_status D -> N;

Comment Full text

CLGN attributes changed

  • Technical Exchange News
  • March 31, 2026, 02:14 UTC
  • 19
  • 0 comments

CLGN attributes changed: Attr: Fin_status N -> D;

Comment Full text

COLLPLANT BIOTECHNOLOGIES LTD (CLGN)

  • Technical Exchange News
  • March 31, 2026, 02:14 UTC
  • 23
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

XILIO THERAPEUTICS, INC. (XLO)

  • Technical Exchange News
  • March 31, 2026, 01:40 UTC
  • 26
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

LIFEWARD LTD. (LFWD)

  • Technical Exchange News
  • March 31, 2026, 01:40 UTC
  • 24
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

HARVARD BIOSCIENCE INC (HBIO)

  • Technical Exchange News
  • March 31, 2026, 01:40 UTC
  • 23
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

COLLPLANT BIOTECHNOLOGIES LTD (CLGN)

  • Technical Exchange News
  • March 31, 2026, 01:40 UTC
  • 25
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Hennessy Capital Investment Corp. VIII - Share Rights (HCICR)

  • Technical Exchange News
  • March 30, 2026, 13:10 UTC
  • 19
  • 0 comments

Hennessy Capital Investment Corp. VIII - Share Rights (HCICR) was added to the exchange traded list on NASDAQ

Comment Full text
  • Previous
  • 263
  • 264
  • 265
  • 266
  • 267
  • Next

Search

News categories

  • Technical Exchange News(14168)
  • Event(6229)
  • SEC News(361397)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222260)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin